Asset Management One
HAE icon

Asset Management One’s Haemonetics HAE Stock Holding History

Asset Management One’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-233
Closed -$20.3K – 984
2023
Q4 		$20.3K Buy
+233
New +$20.1K ﹤0.01% 967
2021
Q2 		– Sell
-31,929
Closed -$3.57M – 1059
2021
Q1 		$3.57M Sell
31,929
-26,927
-46% -$3.33M 0.01% 732
2020
Q4 		$6.99M Buy
58,856
+721
+1% +$77.6K 0.03% 558
2020
Q3 		$5.07M Buy
58,135
+24,694
+74% +$2.16M 0.02% 576
2020
Q2 		$3M Buy
33,441
+8,315
+33% +$840K 0.01% 687
2020
Q1 		$2.5M Buy
+25,126
New +$2.72M 0.01% 665

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Asset Management One's HAE Position: Q1 2024 in Review

Asset Management One sold out of Haemonetics (HAE) in Q1 2024, closing a stake of 233 shares — an estimated $20.3K sold.

Asset Management One first reported a position in HAE in Q1 2020 and held it in 6 quarters. The position peaked at $6.99M in Q4 2020. 298 funds tracked by Wall St. Rank hold HAE as of Q1 2024.

  • Asset Management One reported no remaining Haemonetics position as of Q1 2024 after selling out during the quarter.
  • Asset Management One sold 233 Haemonetics shares in Q1 2024, an estimated $20.3K.
  • Asset Management One first reported a position in Haemonetics in Q1 2020 and held it in 6 quarters.
  • Asset Management One's Haemonetics position peaked at $6.99M in Q4 2020.
  • 298 funds tracked by Wall St. Rank held Haemonetics as of Q1 2024.

Based on Asset Management One's 13F filing for Q1 2024, filed 2 May 2024.